InvestorsHub Logo
Followers 28
Posts 1852
Boards Moderated 0
Alias Born 03/22/2009

Re: None

Saturday, 08/09/2014 8:15:43 PM

Saturday, August 09, 2014 8:15:43 PM

Post# of 235
Some key point take aways for me me from the CC on earnings.
1. good growth continues, however, They are still a ways off from turning a profit.
2.they are the only option for about 10% of epilepsy patients that don't respond to medication. Laser ablation for this set of patients is one of their core markets.
3. European Cleartrace set to lauch in Q4
4. The company is happy that Viualase (a company that they work hand in hand with to reduce the need for a surgery room and a MRI room to one room, reducing surgeon time and hospital use)was bought by Medtronic. They see the purchase price to be an indicator of the value of MRIC's potential value. They think Medtronic intends to grow the Visulase product. They are also happy with the expanded sales force that Medtronic brings. They will will get free sales from their efforts.They also think that the Medtronic buy is indicative of the validation of this form and direction of medicine.